Museum to return remains of 39 people taken during colonial rule in India
The Pitt Rivers Museum, one of the world's leading institutions for anthropology, ethnology and archaeology, holds over 6,000 artifacts from the Naga community in India.
Watch CBS News
The Pitt Rivers Museum, one of the world's leading institutions for anthropology, ethnology and archaeology, holds over 6,000 artifacts from the Naga community in India.
Even if you don't know the meaning of the Oxford University Press' word of the year for 2025, you've probably been a victim of it on social media.
Researchers used advanced technology to digitally "unroll" an ancient Greek text on carbonized papyrus, and now they're reading it.
Scientists monitoring 51 chimpanzees saw sick or injured animals eating certain plant items that were not part of their normal diet.
The parents of a U.K. toddler say it's "absolutely mind-blowing" to see their daughter, enrolled in a gene therapy trial, hear for the first time.
China has yet to condemn the Russian invasion of Ukraine, but Chinese officials have vowed to work toward de-escalation and say they will not offer miltary or financial aid to Moscow. George Magnus, research associate at the China Center at Oxford University, joined CBS News' Anne-Marie Green and Mola Lenghi to discuss how China's economic situation is affecting its stance on Ukraine.
There are promising results on three different coronavirus vaccines, including the leading candidate from the U.K.'s Oxford University. Trials show it provides two kinds of protection against COVID-19. Charlie D'Agata has the latest.
Oxford University Press announced its new edition of Shakespeare's complete works will name Christopher Marlowe as a co-author. CBSN's Elaine Quijano has more on why this happened.
Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.
Kanye West had some fun with his speech at Oxford University. CBSN's Anne-Marie Greene and Vladimir Duthiers share the best moments of Kanye's speech captured on Twitter.
As U.S. raises concerns over AstraZeneca's data reporting, drug company says preliminary info was "consistent with the interim analysis," but full review coming within 2 days.
The British drug maker says the large trial also answered many questions that have arisen about the vaccine. Next step: seeking approval for its use in the U.S.
The drugmaker is working on a potential new vaccine that could be more effective against variants.
The Oxford-AstraZeneca vaccine's "plug and play" platform means it's easy to modify, and scientists expect an update to fight new, troubling variants by the fall.
The university has launched a study to assess the safety of its vaccine with AstraZeneca in children for the first time.
Blanket approval will be welcome news amid vaccine shortages across the bloc of 450 million people and worries about limited trial data for older adults.
But while it's authorized for use, the United Kingdom didn't place any early orders of this American coronavirus vaccine, so it won't be available to Brits until the spring.
An 82-year-old dialysis patient and a scientist who helped develop the Oxford-AstraZeneca vaccine were among the first in the world to get the shot outside of trials.
Cheaper to make and easier to move than other approved vaccines, Oxford and AstraZeneca's formula becoming available as U.K. battles new virus variant.
Another potential coronavirus vaccine is showing promising results. Charlie D'Agata reports from Oxford University in England on the AstraZeneca vaccine trial.
"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," an AstraZeneca spokesperson said.
"I know there was a risk because it's like — it's a trial," 23-year-old Jacob Serrano said. "But I'd rather have us one step closer, no matter what it takes."
Several companies are well into Phase 3 of their COVID-19 vaccine trials here in the U.S. Dr. Bob Lahita joins CBSN to discuss their progress, plus whether the coronavirus can be detected in America's wastewater.
AstraZeneca says the trial data "increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale."
NIH researchers in Montana tested a vaccine being developed by Oxford University using six rhesus macaque monkeys. They say the monkeys that got the vaccine developed protective antibodies against coronavirus. Dr. Jon LaPook reports.